A break-through drug may be the answer to treating Alzheimer's

View descriptionShare

A momentous break-through could move forward the treatment of the most common form of dementia - Alzheimers - after decades of little to no progress.

For the first time, an antibody drug - Lecanemab - is slowing down the degeneration of the brain.

And despite Lecanemab only having an incremental effect, researchers are hailing this as a turning point after years of what some describe as 100 percent failure.

Geneticist Professor John Hardy, who was instrumental in pursuing this line of research 30 years ago, spoke to Tova O'Brien Thursday morning and said the clinical effects are phenomenal.

  • Facebook
  • Twitter
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. Tova

    2,469 clip(s)


The best of Tova.
Social links
Follow podcast
Recent clips
Browse 2,517 clip(s)